TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Parkinson Disease, Multiple Sclerosis, Neurologic Diseases, General
In brief
The goal of the FIT4TeleNEURO pragmatic trial is to verify, in real-life care contexts, the superiority in terms of the effectiveness of early rehabilitation intervention with Telerehabilitation (TR) protocols (TR single Approach, task-oriented - TRsA; TR combined approach, task-oriented and impairment-oriented - TRcA) compared to conventional management (Educational treatment, ET). The main questions it aims to answer are: * Are Telerehabilitation protocols more effective than educational treatment? * Is the TRcA treatment more effective than the TRsA? The study investigates the effects of rehabilitation treatment by comparing the two target cases (Multiple Sclerosis - MS and Parkinson's Diseases - PD). Participants will be subjective to: * 3 time-point of assessment (baseline, post-treatment and follow up) with motor, cognitive and quality-of-life measures * A 5-weeks rehabilitation treatment (4 times/week)
Key facts
- Study ID
- NCT06685744
- Run by
- Fondazione Don Carlo Gnocchi ETS
- People needed
- 300
- Starts
- 2024-10-23
- Expected to finish
- 2026-06-30
- Last updated by the study team
- 2025-03-03
Who can join
Age: 25 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- diagnosis of probable PD according to MDS criteria (Postuma et al., 2015) in staging between 1 and 3 on the Hoehn \& Yahr scale (Goetz et al., 2004) or diagnosis of MS according to the criteria of MC Donald 2010 (Polman et al., 2011) with disability level at the Expanded Disability Status Scale EDSS (Kurtzke, 1983) ≤ 4.5;
- age between 25 and 85 years;
- preserved cognitive level at the Montreal Cognitive Assessment test (MoCA test >15.5) (Santangelo et al., 2015);
- no rehabilitation program in place at the time of enrolment;
- stable drug treatment (last three month) with L-Dopa or dopamine agonists (PD group) or Disease Modifying Therapies (DMTs) (MS group).
You may not qualify if…
- presence of comorbidities that might prevent patients from undertaking a safe home program or determining clinical instability (i.e., severe orthopedic or severe cognitive deficits);
- presence of major psychiatric complications or personality disorders;
- presence of severe impairment of visual and/or acoustic perception;
- falls resulting in injuries or more than 2 falls in the 6 months prior to recruitment (PD and MS groups).
- pregnancy
- relapse ongoing/at least 3 months since the last relapse (MS group);
- presence of "frequent" freezing as recorded at the administration of Section II (daily life activity) of the UPDRS (score ≥ 3) (PD group);
- EDSS-FS (cerebellar function) ≥ 3 (MS group).
Where it is running
- Istituti Clinici Scientifici Maugeri SpA — Bari, Italy (enrolling)
- IRCCS Azienda Ospedaliera Universitaria San Martino — Genova, Italy (enrolling)
- Centro Riabilitativo Villa Beretta — Lecco, Italy (enrolling)
- Fondazione Don Carlo Gnocchi Onlus, IRCCS — Milan, Italy (enrolling)
- University of Modena and Reggio Emilia — Modena, Italy (enrolling)
- Istituto Neurologico Nazionale IRCCS Casimiro Mondino — Pavia, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.